Abilify, an antipsychotic drug from Bristol-Myers Squibb Co., has received additional FDA clearance for the treatment of bipolar disorder in children 10 years and older. The company currently markets the drug for schizophrenia patients aged 13 and up and adults with bipolar disorder and major depression.

Full Story:

Related Summaries